Log-in / Create Account  
Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Evidence-Based Approaches to Reducing Medication Misadventures Caused by Drug-Drug Interactions
Track: Sessions
Program Code: 207-L01
Date: Monday, December 4, 2006
Time: 2:00 PM to 5:00 PM 
Location: Ballroom D (CC)
MODERATOR:   Click the plus sign to see more detailed information about each speaker.
 John Murphy, Pharm.D., Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
SPEAKER(S):   Click the plus sign to see more detailed information about each speaker.
 John Horn, PharmD, Associate Director of Pharmacy, University of Washington and UWMC
Designing an Effective Screening Program
Daniel C. Malone, Ph.D., B.S.Pharm., Professor, The University of Arizona College of Pharmacy, Tucson
Identification of Clinically Significant Drug-Drug Interactions and Management Strategies
 John Murphy, Pharm.D., Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
Drug Interaction Screening - What Pharmacists and Prescribers Do
Description
Learning Objectives:
  • Describe differences in standard drug-drug interaction compendia.
  • Identify several clinically significant drug-drug interactions.
  • Identify factors associated with the prevalence of drug-drug interactions.
  • List common methods to categorize the severity of drug-drug interactions.
  • Discuss the problems that can occur when drug interaction screening prompts are ignored or inadequately managed.
  • Evaluate the opportunities and barriers for developing an approach to drug interaction screening that protects patients and is manageable in real life settings.

    • Handout Online
    (Attendees only)
    (Code: 207-L01)
    Regular Attendee:Free
    Attendees Login